118 related articles for article (PubMed ID: 8643200)
1. Association of high-flux dialysers and bacterial contamination of dialysate-induced chronic release of cytokines in haemodialysis patients.
Perez-Garcia R; Anaya F; Chisvert J; Valderrabano F
Nephrol Dial Transplant; 1995 Nov; 10(11):2164-6. PubMed ID: 8643200
[No Abstract] [Full Text] [Related]
2. Use of ultrafiltered dialysate is associated with improvements in haemodialysis-associated morbidity in patients treated with reused dialysers.
Ouseph R; Jones S; Dhananjaya N; Ward RA
Nephrol Dial Transplant; 2007 Aug; 22(8):2269-75. PubMed ID: 17400564
[TBL] [Abstract][Full Text] [Related]
3. Incidence of pyrexia in patients undergoing haemodialysis.
Egwari LO; Mendie UE
West Afr J Med; 1996; 15(2):101-6. PubMed ID: 8855673
[TBL] [Abstract][Full Text] [Related]
4. Profound mishandling of protein glycation degradation products in uremia and dialysis.
Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
[TBL] [Abstract][Full Text] [Related]
5. Short bacterial DNA fragments: detection in dialysate and induction of cytokines.
Schindler R; Beck W; Deppisch R; Aussieker M; Wilde A; Göhl H; Frei U
J Am Soc Nephrol; 2004 Dec; 15(12):3207-14. PubMed ID: 15579524
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis.
Lonnemann G; Koch KM
Nephrol Dial Transplant; 2001; 16 Suppl 4():17-22. PubMed ID: 11402092
[No Abstract] [Full Text] [Related]
7. Microbiological quality requirements for dialysate: is it time for a change?
Ward RA; Sadler JH
Nephrol News Issues; 2002 Nov; 16(12):26-29, 33-4, 36 passim. PubMed ID: 12452108
[No Abstract] [Full Text] [Related]
8. High level of recovery of fungi from water and dialysate in haemodialysis units.
Arvanitidou M; Spaia S; Velegraki A; Pazarloglou M; Kanetidis D; Pangidis P; Askepidis N; Katsinas C; Vayonas G; Katsouyannopoulos V
J Hosp Infect; 2000 Jul; 45(3):225-30. PubMed ID: 10896802
[TBL] [Abstract][Full Text] [Related]
9. Estimating total urea removal and protein catabolic rate by monitoring UV absorbance in spent dialysate.
Uhlin F; Fridolin I; Lindberg LG; Magnusson M
Nephrol Dial Transplant; 2005 Nov; 20(11):2458-64. PubMed ID: 16077147
[TBL] [Abstract][Full Text] [Related]
10. Rapid evolutionary papules in a uremic patient.
Chen SC; Chang HC; Chu SJ; Wu CP; Tsai SH
J Trauma; 2007 Aug; 63(2):449. PubMed ID: 17693851
[No Abstract] [Full Text] [Related]
11. Identification of the bacteriologicalcontamination of a water treatment line used for haemodialysis and its disinfection.
Morin P
J Hosp Infect; 2000 Jul; 45(3):218-24. PubMed ID: 10896801
[TBL] [Abstract][Full Text] [Related]
12. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
Heinz J; Domröse U; Westphal S; Luley C; Neumann KH; Dierkes J
Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of fungi in water used at a haemodialysis centre.
Pires-Gonçalves RH; Sartori FG; Montanari LB; Zaia JE; Melhem MS; Mendes-Giannini MJ; Martins CH
Lett Appl Microbiol; 2008 May; 46(5):542-7. PubMed ID: 18363650
[TBL] [Abstract][Full Text] [Related]
14. Review: Clinical usefulness of ultrapure dialysate--recent evidence and perspectives.
Masakane I
Ther Apher Dial; 2006 Aug; 10(4):348-54. PubMed ID: 16911188
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
[TBL] [Abstract][Full Text] [Related]
16. [Anaphylactic shock in hemodialysis: apropos of 2 cases].
Bouvier P; Barnouin F; Briat C; Soutif C; Pollini J
Nephrologie; 1989; 10(1):40-1. PubMed ID: 2716943
[No Abstract] [Full Text] [Related]
17. The role of contaminated dialysate in hemodialysis-associated cytokine production.
Lonnemann G
Contrib Nephrol; 1990; 86():121-7. PubMed ID: 2078948
[No Abstract] [Full Text] [Related]
18. [Blood purification and endotoxin].
Suzue N; Minakuti J
Nihon Rinsho; 2004 May; 62 Suppl 5():223-6. PubMed ID: 15197919
[No Abstract] [Full Text] [Related]
19. [Proatherogenic changes induced by hemodialysis; probably a result of bio-incompatibility].
Nubé MJ; Vervloet MG
Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2540-4. PubMed ID: 11191788
[TBL] [Abstract][Full Text] [Related]
20. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Attman PO; Ottosson P; Samuelsson O; Eriksson UG; Eriksson-Lepkowska M; Fager G
Nephrol Dial Transplant; 2005 Sep; 20(9):1889-97. PubMed ID: 15928099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
